[1]王坤英a,张蓬杰,王剑茹b,等.肾移植受者早期血清25- 羟基维生素D 水平对急性排斥反应的预测价值研究[J].现代检验医学杂志,2024,39(04):138-142.[doi:10.3969/j.issn.1671-7414.2024.04.025]
 WANG Kunyinga,ZHANG Pengjie,WANG Jianrub,et al.Study on the Predictive Value of Serum 25-Hydroxyvitamin D Level in Early Renal Transplantation for Acute Rejection[J].Journal of Modern Laboratory Medicine,2024,39(04):138-142.[doi:10.3969/j.issn.1671-7414.2024.04.025]
点击复制

肾移植受者早期血清25- 羟基维生素D 水平对急性排斥反应的预测价值研究()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第39卷
期数:
2024年04期
页码:
138-142
栏目:
论著
出版日期:
2024-07-15

文章信息/Info

Title:
Study on the Predictive Value of Serum 25-Hydroxyvitamin D Level in Early Renal Transplantation for Acute Rejection
文章编号:
1671-7414(2024)04-138-05
作者:
王坤英a2张蓬杰3王剑茹1b陈好雨1c游瑞君1a梁娇霞1a
(1. 山西省第二人民医院a. 肾病实验室;b. 医教科;c. 肾移植中心,太原 030012;2. 山西省针灸医院门诊办,太原 030006;3. 陕西省人民医院肾病血透中心,西安 710068)
Author(s):
WANG Kunying1a2ZHANG Pengjie3 WANG Jianru1b CHEN Haoyu1cYOU Ruijun1aLIANG Jiaoxia1a
(1a. Nephropathy Laboratory;1b. Department of Medical Education;1c. Department of Kidney Transplantation Center,the Second People’s Hospital of Shanxi Province, Taiyuan 030012, China;2. Shanxi Acupuncture Hospital Outpatient Office, Taiyuan 030006, China;3. Nephropathy Hemodialysis Center, Shaanxi Provincial People’s Hospital, Xi’an 710068, China)
关键词:
肾移植25- 羟基维生素D急性排斥反应
分类号:
R699.2;R446.112
DOI:
10.3969/j.issn.1671-7414.2024.04.025
文献标志码:
A
摘要:
目的 探讨血清25- 羟基维生素D[25-hydroxy vitamin D, 25(OH)D]水平对肾移植急性排斥反应(acuterejection,AR)的预测价值。方法 选取2019 年1 月~ 2022 年8 月山西省第二人民医院同种异体肾移植受者324例。收集受者临床资料,分别采用化学发光免疫法和比色法检测移植术后早期(1月内)血清25(OH)D,甲状旁腺素(parathyroid hormone,PTH)和钙、磷水平,记录检测季节,观察移植术后一年内是否发生AR。定义25(OH)D 水平≥ 20ng/ml 为正常,≥ 12ng/ml~ < 20ng/ml 为不足和< 12ng/ml 为缺乏,并分为25(OH)D 正常组(n=106)、不足组(n=112)和缺乏组(n=106)。按照是否发生AR 分为AR 组(n=51)和非AR 组(n=273)。分析血清25(OH)D 水平基本情况,比较25(OH)D 三组血清PTH,钙、磷水平和季节以及AR 发生率的差异,多因素Logistic 回归分析AR 发生的影响因素,受试者工作特征(receiver operating characteristic,ROC)曲线分析血清25(OH)D 水平对AR 的预测价值。结果 血清25(OH)D 缺乏或不足发生率为67.28%(218/324)。25(OH) 正常组、不足组和缺乏组血清PTH 水平分别为75.44(46.42,113.23)pg/ml,78.29(58.27,152.10)pg/ml 和86.84(54.64,127.3)pg/ml,AR 发生率分别为2.47%(8/324),6.17%(20/324)和7.10%(23/324),均为缺乏组最高,正常组最低,差异具有统计学意义(H==6.784,χ2=8.580,均P < 0.05)。25(OH)D 缺乏(OR=3.340,95% CI:1.409 ~ 7.916),25(OH)D 不足(OR=2.442,95% CI:1.006 ~ 5.925)和人类白细胞抗原(human leucocyte antigen,HLA)错配(4~6 个)(OR=2.117,95% CI:1.027 ~ 4.363)是AR 发生的独立危险因素(均P < 0.05)。血清25(OH)D 水平预测AR 的曲线下面积(area under curve, AUC)为0.702(95% CI:0.625 ~0.779),最佳截断值为13.59ng/ml,特异度和灵敏度分别为66.7%,65.6%。结论 25(OH)D 缺乏(< 12ng/ml)或不足(≥ 12ng/ml ~< 20ng/ml)是肾移植患者发生AR 的独立危险因素,血清25(OH)D 水平对AR 有一定预测价值。
Abstract:
Objective To investigate the predictive value of serum 25-hydroxyvitamin D [25(OH)D] level in early renal transplantation for acute rejection (AR). Methods A total of 324 renal transplant recipients from January 2019 to August 2022 in the Second People’s Hospital of Shanxi Province were selected. The clinical data of the recipients were collected. The levels of serum 25(OH)D, parathyroid hormone (PTH), and calcium, phosphorus in early (within 1 month) transplantation were detected by chemiluminescence immunoassay and colorimetry, respectively. The detection season was recorded, and the occurrence of AR within 1 year after renal transplantation was observed. The 25(OH)D level ≥ 20ng/ml was defined as normal, ≥ 12 ng/ml ~ < 20 ng/ml as insufficient and < 12ng/ml as deficient,they were divided into of 25(OH)D normal group(n=106), insufficient group(n=112)and deficient group(n=106). According to the occurrence of AR, they were divided into AR group (n=51) and non-AR group (n=273). The basic situation of serum 25(OH)D level was analyzed. The differences in serum PTH, calcium, phosphorus levels and seasons as well as AR incidence among the three groups of 25(OH)D were compared. Multivariate logistic regression was used to analyze the influencing factors of AR, and receiver operating characteristic (ROC) curve was used to analyze the predictive value of serum 25(OH)D level for AR. Results The incidence of serum 25(OH)D deficiency or insufficiency was 67.28% (218/324). In the 25(OH)D normal group, insufficient group and deficiency group, the serum PTH levels were 75.44 (46.42,113.23) pg/ml, 78.29 (58.27,152.10) pg/ml and 86.84 (54.64,127.3)pg/ml, and the incidences of AR were 2.47% (8/324), 6.17% (20/324) and 7.10%(23/324), respectively. All of them were the highest in the deficiency group and the lowest in the normal group, and the differences were significant (H = 6.784, χ2 = 8.580, all P < 0.05). Additionally, 25(OH)D deficiency (OR = 3.340, 95% CI: 1.409 ~ 7.916), 25(OH)D insufficiency (OR = 2.442, 95% CI: 1.006 ~ 5.925) and human leucocyte antigen (HLA) mismatch (4 ~ 6) (OR = 2.117, 95% CI: 1.027 ~ 4.363) were independent risk factors for AR (all P < 0.05). The area under the curve (AUC) of serum 25(OH)D level in predicting AR was 0.702 (95% CI: 0.625 ~ 0.779), the optimal cut-off value was 13.59 ng/ml, the specificity and the sensitivity were 66.7 % and 65.6 %,respectively. Conclusion In this study, 25(OH)D deficiency (< 12ng / ml) or insufficiency ( ≥ 12 ~ < 20ng / ml) was an independent risk factor for AR, and serum 25(OH)D level may have a certain predictive value for AR.

参考文献/References:

[1] 中华医学会器官移植学分会. 肾移植排斥反应临床诊疗技术规范(2019 版)[J]. 器官移植, 2019, 10(5):505-512. Branch of Organ Transplant of Chinese the Medical Association. Technical specification for clinical diagnosis and treatment on rejection of renal transplantation (2019 edition)[J]. Organ Transplantation, 2019, 10(5): 505-512.
[2] 陈燕媚, 周继昌. 维生素D 对免疫系统作用机制的研究进展[J]. 营养学报, 2020, 42(3): 301-307. CHEN Yanmei, ZHOU Jichang. Advances in the mechanisms of the action of vitamin D on immune system [J]. Acta Nutrimenta Sinica, 2020, 42(3): 301-307.
[3] 马江涛, 柴爽, 万雷, 等. 维生素D 缺乏对骨和骨外作用研究进展[J]. 中国骨质疏松杂志, 2020, 26(1):109-113. MA Jiangtao, CHAI Shuang, WAN Lei, et al. Research progress in the effect of vitamin D deficiency on skeletal and extraskeletal health [J]. Chinese Journal of Osteoporosis, 2020, 26(1): 109-113.
[4] 夏征, 周林. 维生素D3 在移植免疫中的应用进展[J].器官移植, 2023, 14(2): 313-318. XIA Zheng, ZHOU Lin. Application progress in the role of vitamin D3 in transplantation immunity[J]. Organ Transplantation, 2023, 14(2): 313-318.
[5] KOIMTZIS G, STEFANOPOULOS L, BROOKER V, et al. The role of vitamin D in kidney transplantation outcomes: a systematic review[J]. Life(Basel), 2022, 12(10): 1664.
[6] LEE J R, DADHANIA D, AUGUST P, et al. Circulating levels of 25-hydroxyvitamin D and acute cellular rejection in kidney allograft recipients[J]. Transplantation, 2014, 98(3): 292-299.
[7] THORSEN I S, BLESKESTAD I H, ?SBERG A, et al. Vitamin D as a risk factor for patient survival after kidney transplantation: A prospective observational cohort study[J]. Clinical Transplantation, 2019, 33(5): e13517.
[8] MIRZAKHANI M, MOHAMMADKHANI S, HEKMATIRAD S, et al. The association between vitamin D and acute rejection in human kidney transplantation: A systematic review and meta-analysis study[J]. Transplant Immunology, 2021, 67: 101410.
[9] BUYUKDEMIRCI S, OGUZ E G, CIMEN S G, et al. Vitamin D deficiency may predispose patients to increased risk of kidney transplant rejection[J]. World Journal of Transplantation, 2022, 12(9): 299-309.
[10] MOSCA M, LION-LAMBERT M, BIENAIM? F, et al. Association between 25(OH) vitamin D and graft survival in renal transplanted children[J]. Pediatric Transplantation, 2020, 24(7): e13809.
[11] VURAL T, YILMAZ V T, KOKSOY S, et al. Evaluation of the effect and predictive role of vitamin D and vitamin D receptor expression in CD4+, CD8+, CD14+, CD56+ cells on the development of chronic rejection and graft functions in kidney transplant patients[J]. International Urology and Nephrology, 2023, 55(10): 2589-2598.
[12] 中华人民共和国国家卫生健康委员会.WS/T 677-2020 人群维生素D 缺乏筛查方法[S]. 北京: 中国标准出版社, 2020. National Health Commission of the People’s Republic of China. WS/T 677-2020:Method for vitamin D deficiency screening [S].Beijing: Standards Press of China, 2020.
[13] 潘刚, 王谨涵, 席春生. 维生素D 在肾移植中应用的研究进展[J]. 实用药物与临床, 2020, 23(4): 376-379. PAN Gang, WANG Jinhan, XI Chunsheng. Research progress in the application of vitamin D in renal transplantation[J]. Practical Pharmacy and Clinical Remedies, 2020, 23(4): 376-379.
[14] BATTAGLIA Y, COJOCARU E, FIORINI F, et al. Vitamin D in kidney transplant recipients[J]. Clinical Nephrology, 2020, 93(2): 57-64.
[15] TIMALSINA S, SIGDEL M R, BANIYA S, et al. Status of vitamin D and parameters of calcium homeostasis in renal transplant recipients in Nepal: a cross sectional study[J]. BMC Nephrology, 2018, 19(1): 290.
[16] HOLICK M F, BINKLEY N C, BISCHOFF-FERRARI H A, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline[J]. Journal of Clinical Endocrinology and Metabolism, 2011, 96(7): 1911-1930.
[17] 杨雄, 尹爱萍. 慢性肾脏病不同分期患者血清多项骨代谢指标变化与成纤维细胞生长因子23 的相关性分析[J]. 现代检验医学杂志, 2019, 34(4): 58-61,66. YANG Xiong, YIN Aiping. Analysis of the correlation between serum bone metabolism and fibroblast growth factor 23 in patients with chronic kidney disease at different stages [J]. Journal of Modern Laboratory Medicine, 2019, 34(4): 58-61, 66.
[18] 李宁. 肾移植术后矿物质和骨异常[J]. 器官移植,2019, 10(5): 559-569. LI Ning. Mineral and bone abnormalities after renal transplantation[J]. Organ Transplantation, 2019, 10(5): 559-569.
[19] 李敏, 孙江漫, 孟祥兆, 等. 北京地区老年人群血浆维生素A, D 和E 水平检测结果分析[J]. 现代检验医学杂志, 2022, 37(5): 159-163. LI Min, SUN Jiangman, MENG Xiangzhao, et al. Analysis of plasma vitamin A, D and E levels in Beijing elderly population[J]. Journal of Modern Laboratory Medicine, 2022, 37(5): 159-163.
[20] CARLBERG C. Vitamin D signaling in the context of innate immunity: focus on human monocytes[J]. Frontiers in Immunology, 2019, 10: 2211.

相似文献/References:

[1]王坤英,张蓬杰a,王慧英,等.肾移植术后肺部感染时间、病原菌分布及耐药性分析[J].现代检验医学杂志,2016,31(05):97.[doi:10.3969/j.issn.1671-7414.2016.05.026]
 WANG Kun-ying,ZHANG Peng-jiea,WANG Hui-ying,et al.Analysis of the Onset Time,Pathogen Distribution and Drug Resistance in Kidney Transp-Lant Patients with Lung Infection[J].Journal of Modern Laboratory Medicine,2016,31(04):97.[doi:10.3969/j.issn.1671-7414.2016.05.026]
[2]徐翠香a,靳占奎b,王 曦,等.Luminex技术检测肾移植患者血清IL-17预测急性排斥反应的回顾性研究徐翠香,[J].现代检验医学杂志,2017,32(04):87.[doi:10.3969/j.issn.1671-7414.2017.04.024]
 XU Cui-xianga,JIN Zhan-kuib,WANG Xi,et al.Retrospective Study of Detection of Serum IL-17 for Predicting Early Acute Renal Allograft Rejection by Luminex Technique[J].Journal of Modern Laboratory Medicine,2017,32(04):87.[doi:10.3969/j.issn.1671-7414.2017.04.024]
[3]李贤见,黄裕林,易 宏,等.重庆市开州地区 0~6岁儿童 25-羟基维生素 D水平调查及相关危险因素分析[J].现代检验医学杂志,2019,34(06):130.[doi:10.3969 / j.issn.1671-7414.2019.06.033]
 LI Xian-jian,HUANG Yu-lin,YI Hong,et al.Investigation of 25-Hydroxyvitamin D Level and Analysis of Related Risk Factors in Children Aged 0~6 Years in Kaizhou District of Chongqing[J].Journal of Modern Laboratory Medicine,2019,34(04):130.[doi:10.3969 / j.issn.1671-7414.2019.06.033]
[4]魏菁菁,王冬梅,胡 俊,等.肾移植术后患者血液他克莫司代谢率(C0/D 值) 对肝肾功能的影响研究[J].现代检验医学杂志,2020,35(03):112.[doi:10.3969/j.issn.1671-7414.2020.03.030]
 WEI Jing-jing,WANG Dong-mei,HU Jun,et al.Metabolic Rate of Tacrolimus(C0/D ratio) and the Effects on Hepatic Function Renal Function after Renal Transplantation[J].Journal of Modern Laboratory Medicine,2020,35(04):112.[doi:10.3969/j.issn.1671-7414.2020.03.030]

备注/Memo

备注/Memo:
基金项目:山西省卫生健康委“四个一批”科技兴医创新计划重点攻关专项(2023XM027)。
作者简介:王坤英(1978-),女,硕士,副主任技师,研究方向:肾病检验及研究,Email: wangkunying_2000@163.com。
通讯作者:张蓬杰(1975-),男,硕士,副主任医师,研究方向:肾病临床及研究,E-mail:13149254918@163.com。
更新日期/Last Update: 2024-07-15